Catalyst Wire Dossier Catalyst Wire Dossier

MARGENZA

MARGETUXIMAB-CMKB · TerSera Therapeutics LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MARGENZA, covering 2020-12-16 to 2025-01-15. Get the full timeline:

Most recent: FDA Approved: MARGENZA — Supplemental Application (TerSera Therapeutics LLC)

See pricing